Saint Luke's Hospital-Quakertown Campus — Quakertown, Pennsylvania

Saint Luke's Hospital-Quakertown Campus is a clinical research site located in Quakertown, Pennsylvania, United States 18951.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Luke's Hospital-Quakertown Campus has participated in 14 clinical trials with 13 currently active.

Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), NRG Oncology, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's Hospital-Quakertown Campus?

Saint Luke's Hospital-Quakertown Campus has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's Hospital-Quakertown Campus conducted?

Saint Luke's Hospital-Quakertown Campus has 14 clinical trials on record, with 13 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.

Is Saint Luke's Hospital-Quakertown Campus accredited by Crixeo Health?

Yes — Saint Luke's Hospital-Quakertown Campus holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Luke's Hospital-Quakertown Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.